CHARLOTTESVILLE, Virginia, January 12 /PRNewswire/ — Biovista Inc. today announced that the U.S. Food and Drug Administration (FDA) has licensed its technology platform to help analyze, identify, and better understand the way certain drugs can cause harmful side effects. The FDA’s Office of Clinical Pharmacology, within the Center for Drug Evaluation and Research (CDER), will … Read More
Author: Vassilis Virvilis
Biovista to present at the 2nd International Conference on Drug Discovery and Therapy
Charlottesville, VA (11 January 2010) Biovista Inc. announced today that it will be present at the 2nd International Conference on Drug Discovery and Therapy (ICDDT 2010) held in Dubai, UAE, Jan 31 – February 4th, 2010. Biovista’s CEO, Dr. Andreas Persidis will give an invited lecture highlighting the efficiencies of repositioning as a development strategy, … Read More
Novus Biologicals awards contract to Biovista Inc. to drive its web-based Novus Explorer service
CHARLOTTESVILLE, Virginia, December 17 /PRNewswire/ — Biovista Inc. today announced the signing of a contract with Novus Biologicals for access to Biovista’s BEA literature mining platform. BEA will be used to power Novus Explorer, a new service that Novus Biologicals is offering to visitors of its web site. Driven by BEA, Novus Explorer will allow … Read More
Biovista Inc. Named Top Innovator in Life Sciences
CHARLOTTESVILLE, Virginia, December 16 /PRNewswire/ — Biovista Inc. today announced that it was awarded the 2009 Top Innovator Presentation Award in Healthcare, at the 2009 New England Venture Summit, held on December 8th at Dedham, MA. The award, which recognizes cutting edge private companies driving the future of innovation, was granted to Biovista who competed … Read More
TIF awards contract to Biovista for the installation of the JAnaemia patient record management system
CHARLOTTESVILLE, Virginia and ATHENS, Greeece, December 1 /PRNewswire/ — Biovista Inc. today announced the signing of a new collaboration agreement with the Thalassaemia International Federation (TIF) for the installation and support of its JAnaemia patient record management system. JAnaemia, which has been customized, in this case for beta thalassaemia patients, will be initially installed at … Read More